Skip to search formSkip to main contentSkip to account menu

Cyclokapron

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Objectives: To evaluate the efficacy of a Gonadotropin Releasing Hormone Agonist (GnRH-a) concomitantly with an aromatase… 
2015
2015
Current interest of orthopaedic surgeons in tranexamic acid (TXA) is rapidly increasing in the literature, and controversial… 
Review
2003
Review
2003
This article discusses evidence for the role of pharmacological interventions such as the protease inhibitor aprotinin (Trasylol… 
1999
1999
Objective To evaluate the effect of pre-operative administration of tranexamic acid in preventing prolonged post-operative… 
1994
1994
Plasminogen activator inhibitor-1 (PAI-1) deficiency causes a rare bleeding disorder by allowing excessive fibrinolysis to occur… 
Highly Cited
1991
Highly Cited
1991
A considerable number of agents have been proposed as causing ligneous conjunctivitis. We report the first case to arise as a… 
Highly Cited
1973
Highly Cited
1972
Highly Cited
1972
In a double-blind trial tranexamic acid (AMCA, Cyclokapron), 1 g three times a day for five days, significantly reduced blood… 
Highly Cited
1970
Highly Cited
1970
In a double-blind trial tranexamic acid (Cyclokapron) 1 g. four times a day for the first four days of menstruation…